Session 4: Making a case - ROI and business case for tobacco control ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research Group.

Slides:



Advertisements
Similar presentations
Implementing NICE guidance
Advertisements

NICE Public Health Guidance and return on investment tools Kay Nolan ( Wednesday 26 th March 2014.
Session 2: Assessing cost- effectiveness of individual level interventions ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research.
How do we achieve cost effective cancer treatments in the UK? Professor Peter Littlejohns Department of Public Health and Primary Care.
International workshop to discuss the science of asset management, 9 th December 2011 Long term investment planning Developing practical strategic investment.
Determining Your Program’s Health and Financial Impact Using EPA’s Value Proposition Brenda Doroski, Director Center for Asthma and Schools U.S. Environmental.
Session 3: Assessing cost- effectiveness of population level interventions ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research.
Money talks. Social Return on Investment The economic and social value created by social firms Sheila Durie The SROI Network and the SROI Project in Scotland.
Money talks. The economic case The economic case is strong for investment in social firms and in employing people with disabilities In the UK, Government.
DCRS CONFERENCE 2012 THE VALUE FOR MONEY OF BEHAVIOUR CHANGE DR GRAHAM LISTER PROFESSOR IN HEALTH AND SOCIAL CARE LONDON SOUTH BANK UNIVERSITY.
Incorporating considerations about equity in policy briefs What factors are likely to be associated with disadvantage? Are there plausible reasons for.
The role of economic modelling – a brief introduction Francis Ruiz NICE International © NICE 2014.
Economic Analysis and Management Todd Wagner, PhD.
EXPECTED OUTCOMES The study will provide information on the impact of tobacco use on health from epidemiological, social and economic perspectives in relation.
Making the case for investment in local tobacco control – tools available SEPHIG, City of Westminster Archives Centre, London 23 September 2014 Allan Gregory,
Session 1: Review of Economic Evaluation and Tobacco Control ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research Group Brunel.
An Introduction to Social Simulation Andy Turner Presentation as part of Social Simulation Tutorial at the.
Evidence to support the effectiveness of Brief Interventions (NICE Guidelines)
Budget Impact Analysis and Return on Investment Usa Chaikledkaew, Ph.D.
Healthy Ireland A framework for improved health and wellbeing Healthy Food for All 20 November 2013 Dr Miriam Owens.
 2007 Johns Hopkins Bloomberg School of Public Health Section B A Look Ahead: Summary of Main Findings.
Back to Basics: Health Economics Gavin Lewis, Head of Health Economics, Roche BOPA, Brighton, 18 th October, 2009 HCMR00008 / Date of Preparation October.
ND Topical Call Innovative Uses of Title I, Part D, Funds: Cost-Benefit Analysis to Drive Decisionmaking (Call 1) February 5, 2014.
Knowing what you get for what you pay An introduction to cost effectiveness FETP India.
Le rôle de la réduction de dommages dans la lutte antitabac The role of harm reduction in tobacco control Lars M. Ramström Institute for Tobacco Studies.
Changes in lifestyle risk factors: Health and economic impact as estimated by the population based RHS- model Inna Feldman, PhD Social.
L. Currie 1 ; S. Keogan 1 ; P. Campbell 2 ; M. Gunning 3 Z. Kabir 1 ; V. Clarke 1 and L. Clancy 1 1 Research Institute for a Tobacco Free Society, 2 Health.
This presentation arises from the project HEALTH EQUITY – 2020 which has received funding from the European Union, in the framework of the Health Programme.
Cost-Effectiveness Thresholds Professor of Health Economics
Economic analysis of smoking cessation in secondary care A working paper based on the work commissioned by the UK National Institute for Health and Care.
Meeting of the High Level Group on Administrative Burdens Dr. Johannes Ludewig Chairman of the Nationaler Normenkontrollrat Brussels, 23 July 2013.
Skills for Care Conference 2015 Leadership Workshop Achieving success through: effective leadership and management workforce development Maureen Hinds:
The Broader Impact of Incentive Schemes to Enable Smoking Cessation in Pregnancy Tina Williams June 2015.
MediSave TM : New Software to Calculate the Return on Investment of Tobacco Control Programs Steven S. Foldes, Ph.D. and Anju Joglekar, Ph.D. Blue Cross.
International Health Policy Program -Thailand Journal Club: Tobacco and Lung Cancer Risk: A Systematic Review and Meta-Analysis Jiraboon Tosanguan.
Assessing viability in plan making and HCA support on viability Growth Point Best Practice Network Michael Rich 11 th May, 2012.
“Analytical Tools and Data Collection” April 2009 EuropeAid/125317/D/SER/TR Session 1 Introduction to Role of Impacts Assessment in RIAs.
The effect of socioeconomic differences on smoking uptake in young people in a low prevalence smoking area Emma Regan And Linda Homan The effect of socioeconomic.
© UKCIP 2015 Monitoring, Reporting and Evaluation for Adaptation A brief introduction to the EEA Expert Workshop on MRE Patrick Pringle Deputy Director.
Creating a sporting habit for life. What’s it really worth?: Return on Investment for Physical Activity and Sport Suzanne Gardner Senior Health Manager.
Investing in a healthy community: making the most of NICE’s ROI tools Judith Richardson Health & Social Care Directorate.
Well-being for Travellers Supporting Communities to become Smokefree Val Mills, Smoking Cessation Lead Nicki Blyth, Deputy Team Lead Bucks Smokefree Support.
Employment Social Impact Bonds. Our partnership Numbers4Good and the Centre for Economic and Social Inclusion (Inclusion) are launching a new partnership.
1 Maintaining downward pressure on smoking prevalence Robert West University College London All Party Parliamentary Group on Smoking September 2015.
1 News from the Smoking Toolkit Study: December 2012 University College London December 2012 Robert West.
1 University College London February 2014 Robert West Population impact of tobacco dependence treatment.
Innovative ideas to prevent & control Non-Communicable Diseases through Rural Eye Health Intervention Sarangadhar Samal Kalinga Eye Hospital (An unit of.
If we followed NICE guidelines and treated people with diabetes earlier, patients and the NHS would benefit from a reduction in complications, mortality.
Richard Sekula Head of PH Intelligence NHS Greenwich.
Health equity audit Stuart Harris Public Health Intelligence Analyst Course – Day 4.
APHO’s Technical Work Paul Fryers Deputy Director – East Midlands PHO Technical Advisor – APHO.
PETRA Workshop Tobacco Cessation and Cancer Treatment Dr. Larry Pan, MD, FRCPC Radiation Oncologist Chelsea Soga, MA, BSc RTT Radiation Therapist and Project.
Rebecca Mason Knowsley Metropolitan Borough Council Simon Capewell University of Liverpool 8 th December 2015.
OUR FOCUS FOR 2011 TO 2012 The CfWI produces quality intelligence to inform better workforce planning, that improves people’s lives.
Newquay Pathfinder Initial evaluation findings. Background Newquay Pathfinder (NPF) project commenced June 2012 Supported by Age UK, Cornwall Council.
Burden of Disease and Health Economics: Friends or Foes?
Benjamin Kearns, The University of Sheffield
Magnitude and Cost-Effectiveness
Ailsa Rutter, Director, Fresh: Smokefree North East
Background & Objectives
Stroke Health Economics Project A new NHS resource for data on the health and social care costs of stroke Dr Benjamin Bray.
BRIGHTLIGHT: from first glow to now – what, why and how
Local Tobacco Control Profiles The webinar will start at 1pm
Director, Division of Health Sciences, Brunel University London
Employment Social Impact Bonds
Tobacco Control: How local authorities can make best use of diminishing resources Ailsa Rutter OBE, Director, Fresh - Smokefree North East.
Strategic Environmental Assessment (SEA)
Meeting with EG PHC Ev. underrubrik Förnamn Efternamn.
Tools to support development of interventions Soili Larkin & Mohammed Vaqar Public Health England West Midlands.
Presentation transcript:

Session 4: Making a case - ROI and business case for tobacco control ARCH Technical Workshop Bali August 2014 Matt Glover Health Economics Research Group Brunel University London

Session outline What does ROI mean? Why do we need to know ROI of tobacco control? Introduction to NICE Tobacco ROI tool An example of a business case based on NICE tool

ROI Return on investment Umbrella term used to refer to the return that investing in tobacco control agendas could generate Primarily economic concept (Does my $1 investment give me >$1 benefit?) Wider consequences are being included, not necessarily monetised - SROI

Why ROI matters

NICE Tobacco return on investment tool investment-tool

NICE Tobacco ROI tool Scope: –Develop a toolkit that would estimate economic impact of broader tobacco control (not limited to cessation interventions) –A user friendly version that would generate outputs for different geographical area (e.g. LA, county and region) Timing - challenging: –Provision and funding of public health undergoing major changes –Anecdotal evidence suggests smoking prevalence is falling at a lower rate during recession –Need to ensure that tobacco control and smoking cessation remain a public health priority

Limitations of previous analyses Disparate estimates of the burden –Differences in scope/perspective – i.e. inclusion of indirect costs such as productivity costs –Differences in conditions included and attributable fractions applied Intended to inform national debate on tobacco control –Dominated by estimates of lifetime/long-term impact with minimal resonance for local decision makers –Small area level analysis limited (Callum et al. 2005)

NICE ROI Tool Microsoft Excel based Markov model Begins with total population in selected area Current smokers, ex-smokers, never smokers Interventions may help current smokers to quit but they may relapse too Current smokers are followed for their lifetime to track changes in mortality, health service use, and productivity Cost and QALYs are estimated accordingly

Aim of the tool To explore the economic case for comprehensive tobacco control strategies –Build on the best available evidence on tobacco control –Suitable for use by health and local authorities –Include health and non-health outcomes –Include financial and non-financial consequences

Development of the model Attempt to build on previous analyses (e.g. Flack, Taylor & Trueman 2007) Incremental improvements: –Improved granularity of metrics –Incorporate uptake and passive smoking effects –Capture selected non-health outcomes –Improve interactivity to facilitate bespoke local level analyses

The economic model A Microsoft Excel based model to assist planners and commissioners involved in public health Markov model, following a cohort of current smokers over their lifetime to identify costs and outcomes Results are expressed in four time horizons: –2 years (short term) –5 years –10 years –Lifetime

Markov process Considers cohort of current smokers Each year they become –Current smokers –Former smokers –Die Health outcomes and resource use driven by smoking status

The model ingredients Smokers and former smokers each have a risk of developing a number of smoking attributable conditions & death –CVD, MI, COPD, lung cancer Healthcare resource use, QOL/utility and productivity also dependent on smoking status Data sourced from widely accepted stats/literature

How the model works Model pre-populated with default data, although this can be easily over-written to reflect local knowledge/data Model categorises local population as never-smokers, current smokers or former smokers Current smokers continue to smoke or move to former smokers each year, reflecting quit rates Individuals exit the model as a result of death

“Business case” scenarios Using the tool to build a business case How much is tobacco costing (Baseline scenario)? How much does your Current Package of interventions cost you? What are the benefits of the Current Package? Are there any savings to be made by local businesses, health and social care sectors as well as by people who don't smoke (passive smokers)?

“Business case” scenarios Using the tool to build a business case Does the benefit outweigh the costs? If so, at what time point? What is the ROI of the Current Package? To what extent can the savings made by local businesses pay for investment in the Current Package? At what time point can the investment in cessation programmes pay for itself? What potential improvements could you make by altering your current service provision (Alternative Package)?

Practical example Making Business Cases for: Current practice (i.e. the existing provision) Practice variation (i.e. doing things differently) Discussion to be based on handouts: 1)Report of current practice 2)Report of alternative practice